Nextcure to present at the 20th annual needham virtual healthcare conference

Beltsville, md., april 07, 2021 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the 20th annual needham virtual healthcare conference on april 13th at 12:45 pm eastern time.
NXTC Ratings Summary
NXTC Quant Ranking